These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21907354)

  • 1. A predictive model for amyotrophic lateral sclerosis (ALS) diagnosis.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neurol Sci; 2012 Jan; 312(1-2):68-72. PubMed ID: 21907354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
    Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
    Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive model for earlier diagnosis of suspected age-related macular degeneration patients.
    Sharma NK; Sharma SK; Gupta A; Prabhakar S; Singh R; Anand A
    DNA Cell Biol; 2013 Sep; 32(9):549-55. PubMed ID: 23848218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.
    de Jong SW; Huisman MH; Sutedja NA; van der Kooi AJ; de Visser M; Schelhaas HJ; Fischer K; Veldink JH; van den Berg LH
    Am J Epidemiol; 2012 Aug; 176(3):233-9. PubMed ID: 22791740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis.
    Kraemer M; Buerger M; Berlit P
    Clin Neurol Neurosurg; 2010 Feb; 112(2):103-5. PubMed ID: 19931253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis.
    Cellura E; Spataro R; Taiello AC; La Bella V
    Clin Neurol Neurosurg; 2012 Jul; 114(6):550-4. PubMed ID: 22169158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of fasciculation potentials in the diagnosis of amyotrophic lateral sclerosis].
    Xu YS; Zheng JY; Zhang S; Bao SL; Fan DS
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(7):482-4. PubMed ID: 21418981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The comparison of logistic regression model selection methods for the prediction of coronary artery disease].
    Colak C; Colak MC; Orman MN
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):6-11. PubMed ID: 17347067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
    Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic categories for amyotrophic lateral sclerosis.
    Scotton WJ; Scott KM; Moore DH; Almedom L; Wijesekera LC; Janssen A; Nigro C; Sakel M; Leigh PN; Shaw C; Al-Chalabi A
    Amyotroph Lateral Scler; 2012 Oct; 13(6):502-8. PubMed ID: 22670880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
    de Carvalho M; Swash M
    Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers.
    Khosla R; Rain M; Sharma S; Anand A
    PLoS One; 2021; 16(2):e0247025. PubMed ID: 33606761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum N-acetylaspartate level in amyotrophic lateral sclerosis.
    Simone IL; Ruggieri M; Tortelli R; Ceci E; D'Errico E; Leo A; Zoccolella S; Mastrapasqua M; Capozzo R; Livrea P; Logroscino G
    Arch Neurol; 2011 Oct; 68(10):1308-12. PubMed ID: 21987545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
    J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restless legs syndrome in patients with amyotrophic lateral sclerosis.
    Lo Coco D; Piccoli F; La Bella V
    Mov Disord; 2010 Nov; 25(15):2658-61. PubMed ID: 20669314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
    Thijs V; Peeters E; Theys P; Matthijs G; Robberecht W
    Acta Neurol Belg; 2000 Jun; 100(2):84-90. PubMed ID: 10934559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.